The architect of an historic change in the way patent claims are interpreted explains what it means for AI drafting, and why ...

26 June 2025 Insurance company Cigna claims Bristol Myers Squibb may have caused overpayments of ‘billions’ of dollars after ...

Biocon failed to provide critical information about proposed denosumab product, Amgen claims | Company expects ‘sales erosion ...

8 November 2017 Generic drugs maker Accord Healthcare has lost a battle to have a patent invalidated at the English High ...

26 June 2025 Biotech institute successfully challenges EPO decision revoking key CRISPR patent over priority rights | Appeal ...

17 June 2025 Ex-co-head of life sciences at previous firm brings expertise in multi-jurisdictional patent disputes involving ...

French biopharma giant overturns German rival’s patent at the European Patent Office | Revocation based on insufficient ...

This session brings together experts from Choate, Radius Health, and Syros Pharmaceuticals to examine the current policy ...

David Gindler of Orrick discusses the US Supreme Court’s ruling in Amgen v. Sanofi and what it means for ongoing Section 112 ...

Appeals board overturns previous decision and revokes patent on treatment worth $2bn in 2024 | Teva and Generics UK ...

Trio have worked together for several years at different firms, bringing decades of experience in medical devices, robotics, ...

Insurance company Cigna claims Bristol Myers Squibb may have caused overpayments of ‘billions’ of dollars after allegedly delaying market entry of generic Pomalyst | Lawsuit follows dismissal of ...